Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes.

about

Effectiveness and safety of insulin glargine detemir analysis in patients with type 1 diabetes: systematic review and meta-analysis

P2860

Q58817760-E011DE6A-5249-478E-A6A6-41DF33A3221D

P2860

Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes.

Item

http://www.wikidata.org/entity/Q40258044

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Glucose-lowering effect and gl ...... n people with type 1 diabetes.

@en

type

Item

label

Glucose-lowering effect and gl ...... n people with type 1 diabetes.

@en

prefLabel

Glucose-lowering effect and gl ...... n people with type 1 diabetes.

@en

P1476

Glucose-lowering effect and gl ...... n people with type 1 diabetes.

@en

P2093

A D'Angelo

http://www.w3.org/2001/XMLSchema#string

D Romano

http://www.w3.org/2001/XMLSchema#string

F Querci

http://www.w3.org/2001/XMLSchema#string

I Franzetti

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Prediction of severe hypoglycemia.

Comparison of insulin lispro protamine suspension versus insulin glargine once daily added to oral antihyperglycaemic medications and exenatide in type 2 diabetes: a prospective randomized open-label trial.

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes.

Long-acting basal insulin analogs: latest developments and clinical usefulness.

A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs.

A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.

Comparison of pharmacodynamic intrasubject variability of insulin lispro protamine suspension and insulin glargine in subjects with type 1 diabetes.

Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferior

The glycosylation of hemoglobin: relevance to diabetes mellitus.

P304

554-559

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DOM.12454

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pamela Maffioli

Giuseppe Derosa

P577

2015-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25694300

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes.

about

P2860

P2860

Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921